...cardiovascular diseases, including arterial stenosis, restenosis and atherosclerotic plaque. Bio3 also received non-exclusive rights to Protelica's...
...and commercialize the compounds. Financial terms were not disclosed. Bio3 Research s.r.l. , Milan, Italy Protelica...

...fragments (including BoxA) that bind and antagonize HMGB1 to treat cardiovascular disorders. Bio3 and partner Protelica...
...Francesco Paolo Pilato told SciBX that based on the Nature Medicine findings, "Bio3 Research and Protelica...
...Milan, Italy New York University , New York, N.Y. NovImmune S.A. , Geneva, Switzerland Protelica...